We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Spectral Medical Inc.
An SI Board Since October 2011
Posts SubjectMarks Bans Symbol
473 11 0 EDTXF
Emcee:  Sultan Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
443Spectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on LifetiSultan-9/8/2023
442CORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Sultan-9/7/2023
441Spectral Medical Announces Second Quarter Results and Provides Corporate Update Sultan-8/10/2023
440Spectral Medical Announces Tigris Clinical Trial Update
439Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observationSultan-7/20/2023
438Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial EnSultan-6/20/2023
437Spectral Medical is undervalued, says Paradigm cantechletter.comSultan-6/2/2023
436Spectral Medical Announces First Quarter Results and Provides Corporate Update Sultan-5/16/2023
435Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial EvaluatinSultan-4/18/2023
434Spectral Medical Investor Day April 6 2023 spectraldx.comSultan-4/6/2023
433Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides CSultan-3/24/2023
432CRRT Conference Industry Lunch Symposium Sponsored by Spectral Endotoxin: DetecSultan-3/13/2023
431Spectral Medical Announces the Opening of Two Additional Tigris Clinical Trial SSultan-3/9/2023
430February 2023 Presentation spectraldx.comSultan-2/27/2023
429[X] “Sepsis is a leading cause of death in hospitals. It’s been true for a longSultan-2/9/2023
428Infomed S.A. Announcement 2023First of all, we wish to all of you the best forSultan-1/20/2023
427Spectral Medical Provides Update on Tigris Clinical Trial and Other Business DevSultan-1/12/2023
426Baxter Investor Announcement 2023 (dated Jan 6th) Of interest to Spectral MedicSultan-1/11/2023
425Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate CoSultan-12/13/2022
424Hemodialysis Market Size is projected to reach USD 136.84 Billion by 2031, growiSultan-12/7/2022
423Spectral Medical Inc. Announces Proposed Public Offering of Units and Private PlSultan-10/5/2022
422Spectral Medical Provides Update on Tigris Clinical Trial
421Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Clinical TrialSultan-8/18/2022
420Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical and DSultan-8/8/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):